Paragon Fine and Specialty Chemicals
Paragon Fine and Speciality Chemical Ltd
- P/E
- 4.28
Key Fundamentals
SMEChemicals & PetrochemicalsChemicalsPrice-based figures as of · TTM
- ROCE
- 12.80%
- Debt to Equity
- 0.01
- EPS (TTM)
- ₹11.70
- Book Value
- ₹50.31
- Market Cap
- —
- P/E (TTM)
- 4.28
- P/B
- 1.00
- ROE
- 9.64%
- Dividend Yield
- 0.00%
- EBITDA
- ₹13.70 Cr
- 52W High
- ₹64.90
- 52W Low
- ₹34.10
- Day Range
- ₹49.00 – ₹50.10
- Volume
- 3,600
Peer Comparison
Commodities › Chemicals › Dyes & Pigments › Dyes And Pigments
| ₹1,077.95 | 119.11 | ₹8,488 Cr | 2.43 | 0.46% | 0.54% | 5.46% | ₹9,922 Cr | ₹88 Cr | |
| ₹523.45 | — | ₹3,368 Cr | 0.52 | 0.00% | −9.09% | 3.40% | ₹950 Cr | ₹5,848 Cr | |
| ₹169.69 | 31.08 | ₹2,137 Cr | 1.68 | 0.06% | 1.97% | 5.59% | ₹2,267 Cr | ₹68 Cr | |
| ₹594.75 | 26.68 | ₹1,932 Cr | 2.91 | 0.34% | 12.10% | 12.90% | ₹1,002 Cr | ₹72 Cr | |
| ₹354.35 | 20.84 | ₹1,540 Cr | 2.29 | 0.68% | 7.77% | 11.00% | ₹997 Cr | ₹74 Cr | |
| ₹378.45 | 18.27 | ₹869 Cr | 1.42 | 17.54% | 8.80% | 11.40% | ₹792 Cr | ₹47 Cr | |
| ₹50.10 | 4.28 | ₹96 Cr | 1.00 | 0.00% | 9.64% | 12.80% | ₹60 Cr | ₹6 Cr | |
| Median 7 companies | ₹378.45 | 23.76 | ₹1,932 Cr | 1.68 | 0.34% | 7.77% | 11.00% | ₹997 Cr | ₹72 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 76
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 67
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 29
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 90
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 76
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.00 times its book value
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 5.72% over past five years.
- Company has a low return on equity of 12.6% over last 3 years.
- Debtor days have increased from 114 to 141 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Neutral | 6 | 7 | 6 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Bearish
Overall
Neutral
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 50.05
- Neutral
- MACD (12,26,9)
- −0.73
- Bearish
- SMA (50)
- 50.97
- Bearish
- SMA (200)
- 46.25
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +5.79% |
|---|---|
| 3Y | +1.89% |
| 1Y | −5.17% |
Net profit
| 5Y | +17.61% |
|---|---|
| 3Y | −3.45% |
| 1Y | +50.00% |
Operating cash flow
| 5Y | Turned positive |
|---|---|
| 3Y | Turned positive |
| 1Y | Turned positive |
Operating margin· change in pp
| 5Y | +4.59 pp |
|---|---|
| 3Y | −2.60 pp |
| 1Y | +4.06 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2020 | ₹81.00 Cr |
|---|---|
| Mar 2021 | ₹83.00 Cr |
| Mar 2022 | ₹83.00 Cr |
| Mar 2023 | ₹104 Cr |
| Mar 2024 | ₹121 Cr |
| Mar 2025 | ₹116 Cr |
| Mar 2026 | ₹110 Cr |
Net profit by year
| Mar 2020 | ₹2.00 Cr |
|---|---|
| Mar 2021 | ₹4.00 Cr |
| Mar 2022 | ₹4.00 Cr |
| Mar 2023 | ₹10.00 Cr |
| Mar 2024 | ₹14.00 Cr |
| Mar 2025 | ₹6.00 Cr |
| Mar 2026 | ₹9.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 32 | 72 | 60 | 61 | 52 | 64 | 41 | 69 |
| Expenses | 28 | 61 | 51 | 50 | 50 | 58 | 38 | 59 |
| Operating Profit | 4 | 10 | 9 | 11 | 2 | 6 | 3 | 10 |
| OPM % | 13% | 15% | 15% | 18% | 4.7% | 9% | 7% | 14% |
| Other Income | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| PBT | 4 | 10 | 8 | 11 | 3 | 6 | 2 | 10 |
| Tax % | 25% | 28% | 26% | 26% | 33% | 27% | 20% | 27% |
| Net Profit | 3 | 7 | 6 | 8 | 2 | 4 | 2 | 7 |
| EPS (₹) | 2.03 | 4.81 | 4.16 | 4.25 | 0.87 | 2.15 | 1.02 | 3.61 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 81 | 83 | 83 | 104 | 121 | 116 | 110 |
| Expenses | 77 | 77 | 77 | 89 | 102 | 108 | 97 |
| Operating Profit | 4 | 6 | 6 | 15 | 20 | 9 | 13 |
| OPM % | 4.8% | 8% | 7% | 14% | 16% | 7% | 12% |
| Other Income | 2 | 1 | 2 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | 4 | 6 | 6 | 14 | 19 | 8 | 12 |
| Tax % | 39% | 27% | 27% | 27% | 26% | 28% | 26% |
| Net Profit | 2 | 4 | 4 | 10 | 14 | 6 | 9 |
| EPS (₹) | 1.7 | 3.06 | 3.12 | 6.85 | 7.31 | 3.03 | 4.63 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.1 | 0.1 | 0.1 | 4 | 20 | 20 | 20 |
| Reserves | 3 | 8 | 12 | 19 | 64 | 70 | 79 |
| Borrowings | 12 | 22 | 21 | 25 | 9 | 3 | 1 |
| Other Liabilities | 22 | 20 | 24 | 24 | 13 | 11 | 9 |
| Total Liabilities | 38 | 50 | 58 | 71 | 106 | 104 | 108 |
| Fixed Assets | 6 | 7 | 10 | 9 | 11 | 16 | 19 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 3 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 32 | 43 | 48 | 62 | 94 | 85 | 86 |
| Total Assets | 38 | 50 | 58 | 71 | 106 | 104 | 108 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 12 | −10 | 5 | −2 | 0 | −6 | 5 |
| Investing | −1 | −1 | −4 | −1 | −18 | −2 | 0 |
| Financing | −9 | 9 | −2 | 3 | 29 | −5 | −2 |
| Net Cash Flow | 2 | −1 | −1 | 1 | 12 | −13 | 2 |
| Free Cash Flow | 11 | −11 | 2 | −3 | −3 | −14 | 0 |
| CFO/EBITDA | 316 | −136 | 118 | −7 | 40 | −45 | 55 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 130 | 95 | 95 | 77 | 124 | 141 |
| Inventory Days | 10 | 9 | 83 | 112 | 138 | 124 | 138 |
| Days Payable | 114 | 93 | 135 | 102 | 55 | 42 | 31 |
| Cash Conversion Cycle | −8 | 45 | 43 | 106 | 159 | 206 | 248 |
| Working Capital Days | 8 | 52 | 70 | 91 | 156 | 201 | 230 |
| ROCE % | — | 30% | 21% | 37% | 29% | 9% | 13% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Paragon Fine and Specialty Chemicals insights
59 extracted metrics across FY20–FY26.
Documents
- 28 Sep 2026
- 19 Sep 2026
- 17 Sep 2026
- 9 Sep 2026
Frequently Asked Questions about Paragon Fine and Specialty Chemicals
What does Paragon Fine and Speciality Chemical Ltd do?
Where is Paragon Fine and Speciality Chemical Ltd (PARAGON) listed?
Which sector does Paragon Fine and Speciality Chemical Ltd belong to?
What is the PE ratio of Paragon Fine and Speciality Chemical Ltd?
What is the 52-week high and low of Paragon Fine and Speciality Chemical Ltd?
What is the Return on Equity (ROE) of Paragon Fine and Speciality Chemical Ltd?
Company Information
Incorporated in 2004, Paragon Fine & Speciality Chemical Ltd is in the business of manufacturing chemicals
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PARAGON.md for Paragon Fine and Speciality Chemical Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.